Keloid Treatment Market Synopsis

Keloid Treatment Market Size Was Valued at USD 3.80 Billion in 2023, and is Projected to Reach USD 5.32 Billion by 2032, Growing at a CAGR of 3.80% From 2024-2032.

The keloid treatment market therefore consists of various strategies and treatments used to minimise or eradicate the keloid problem, which is the formation of thick, raised scars resulting from an increased collagen deposition in the healing process. These markets comprise treatments such as corticosteroid injections, silicone gel sheeting, laser therapy, cryotherapy, and surgeries in order to address the client’s requirements for improving appearance and alleviating symptoms including pain and itching. More awareness regarding skin health and treatment technologies, incidence of keloids and especially in people of color, have led to the need for better ways to manage keloids in the healthcare field.

• The market for keloid treatments is rising gradually because of the higher rates of incidence of keloids across the world, which is a type of raised scar that develops from the excessive production of collagen during the skin’s healing process. Keloids are skin irregularities that form following injury, surgery or they may develop on their own, in a significant number of people, more often, the darker skinned. This increasing incidence is leading to increased utilization of good treatment modalities such as surgical excision, intra lesional corticosteroid injections, silicone gel sheets and other novel interventions such as laser therapy and cryotherapy. This is also constraining market through improved treatment technologies and growing information among the health care providers and patients on the available treatment.
• In addition, the keloid treatment market continues to advance as researchers work on discovering better ways of treating this condition in the future practice. Advances in endoscopic surgeries, performances in laparoscopic surgeries, and the development of newer drug molecules are enriching patients’ treatment plans. Its growth can also be attributed to the increasing number of surgeries and overall increased vulnerability to skin injuries, as people aged 65 and above are more likely to book such treatments. With more and more people paying attention to the looks and psychological effects of keloids, customers are looking for early and efficient treatment solutions and thus creating the need for this product.
• Regionally, North America has a largest market share in the keloid treatment due to the higher healthcare spending, better developed healthcare facilities and key market players. However, the Asia-Pacific is expected to have the highest growth rate to come as a result of increased disposable income, improved health care facility, and a growing patient population. The market is highly competitive and the players in this market have adopted strategic partnerships, product acquisitions, and mergers necessary to drive a higher level of growth of product ranges and customer base. All in all, there are great opportunities to develop the keloid treatment market over the next few years due to the growing public awareness of the disease, as well as advancements in treatment methodologies and specializatio

Keloid Treatment Market Trend Analysis

Growing Prevalence of Keloid Scars and the Shift Towards Minimally Invasive Treatments

• The incidence of keloid scar continues to rise, majorly arising from surgeries, accidents, and or other skin conditions including acne. This has led to increased ability by both the patients and the doctors to seek other means through which the keloids can be dealt with. Consequently, there is an increased need for different treatment methods aimed at controlling and preventing formation of keloids. Of these, corticosteroid injections are arguably one of the most popular keloid scar treatments worldwide due to the unique characteristic of flattening and soften keloid scars gradually. However, silicone gel sheets have lately received much attention because they are easy to use, non-invasive, and can easily be used by the patient from the comfort of their home. Laser therapy is also used routinely because the current technology is safe and can effectively heal keloid scars without causing much harm, while helping to give better texture and color to the scarred skin. Excision remains a valuable approach only for those large keloids, however, these formations grow back again after the surgery, so both patients and clinicians should look at other treatment options.
• Some of the growth drivers that I consider as influential in the keloid treatment market are contributing to their growing market trends are; The Role of Minimally invasive procedures in determining patient preferences. In the process of enhancing their knowledge about the available treatment methods, patients go in search of those treatments that not only yield the best results, but also ones that can be implemented in the shortest possible time and at the least risk of post-treatment complications. As less invasive treatment options, chloride-sol gruel congelation like cryotherapy and photo sensitization like photodynamic therapy are becoming favorable treatment modality with tremendous rate of success. Moreover, rolling improvements in technology like ultrasound and radiofrequency are introducing better accuracy of keloid treatment and less patient complaining. This trend corresponds with another fundamental trend in the trajectory of the health care provision by increasingly hinging on patient-specific solutions, including the characteristics of the scar and the patient’s medical history. The awareness, new technology, and patient preference towards non-surgical techniques for keloid treatment are assumed to push the market more in the future, which creates a large interest for both, health care service providers and other stakeholders.

Advancements in Keloid Treatment: Emerging Technologies and Personalized Medicine

• New technologies are only beginning to help with keloid treatment, and all existing therapies have several times increased effectiveness. Freezing of the area of Keloid is also known as cryotherapy which has now got a boost due to its effectiveness and low side effects in reduction of scar size and thus enhancing the outlook. Also, photodynamic therapy, which employs substances affected by particular wavelengths of light, should also prove useful for treating keloids and destroying anomalous tissue without harm to the surrounding skin. The shift in wound care therapies by infusing new biologics which are derived from living tissues and seeks to heal human tissues at molecular level is further enhancing the treatment aeration. These new therapies not only enhance patients’ survivability by providing additional ways to treat Keloids but also expand the options for the kind of treatment available to doctors in the management of scars.
• Besides these inventions in technology, the shift towards individualize treatment as a solution to maintaining keloid scars is becoming a trend. This approach and calls forth the personalisation of treatment where the size, location, and even’ genes’ of the specific keloid under treatment influences treatment procedures. Through current studies of the genetic and molecular processes that lead to keloid scar formation, researchers can better understand keloid development as well as the means for their successful treatment. Wetter health-making knowledge thus opens the door to treatments that deal with the sources of keloids, instead of the keloids. Such an approach is designed to improve the outcomes of treatment not only on a patient level, but also to provide them with the necessary tools to choose their treatment themselves. With ongoing development in the knowledge about keloids, promising possibilities for more target and efficient treatments are on their way, which will influence the keloid treatment market in the future.

Keloid Treatment Market Segment Analysis:

Keloid Treatment Market Segmented based on By Product Type, By Treatment Type and By End-Users

By Product Type, Injectables, laser products (carbon dioxide, pulse-dyed, and others), segment is expected to dominate the market during the forecast period

• Injectables are a very crucial product in the modern society as they offer a method of administering medicine to the body thus acting very fast to produce their therapeutic responses. This makes it useful in places where an urgent response is needed as is the case with emergency medications or those treatments whereby symptoms need to be reduced immediately. The injectables category is a broad group of products and includes biologics, which are highly complex molecules of biological origin, as well as small molecules defined as chemically synthesized substances. Biologics has recently escalated popularity primarily in dermatology and oncology since they are used for diseases like psoriasis, eczema, and different types of cancer. More and more it is becoming possible to devise drugs or other treatments which affect only the required path or cell, meaning that undesired side-effects are minimised and the results for patients are more satisfactory.
• Furthermore, injectable systems are a favoured mode of therapy delivery for their effectiveness and convenience in delivering higher drug levels to the bloodstream or specific tissues. It does not only increases the solubility and dissolution rate of these therapeutic agents but also enables differentiated patient-specific dosage regimens. For example, in oncology practice, injectable chemotherapeutic agents may be given to afford the drug the best possible chance to interact with tumors while sparing the concern organism the brunt of the toxicity. Moreover, injectables are very flexible, that they can be used for different purposes, such as vaccines, control of pain and even administration of hormones. Overtime as new research emerges, the injectables market evolves where new formulations are produced to address the needs of patients and care providers currently.

By End-Users, Hospitals segment held the largest share in 2023

• Hospitals are the fundamental to the health care system and are primary health care delivery facilities where complicated therapies and surgeries take place. These institutions already possess extensive lists of integrated and broad based bibliography which is very important in delivering quality patients care. Surgical units themselves are one of the principal facilities under the hospitals framework, allowing for all types of operations, ranging from the simple to the complicated. Furthermore, specialty infrastructures including imaging systems, robotic surgery, IT based surgical monitoring, and other complex care delivery devices to facilitate complicated medical services. This technological base, in addition to increasing the accuracy of treatments also assists in improving patient results due to timely interventions. Hospitals also play crucial roles in performing different types of medical specialties giving, therefore, different opportunities of interprofessional work and an individualized approach to patients.
• In addition, hospitals are facilities where caregivers are a blend of physicians, surgeons, individual care givers, anaesthetists and allied healthcare professionals providing synergistic comprehensive care. It also creates a multi-disciplinary approach to patient care, where a patient is bound to get all-round caring right from admittance to when he/she is discharged from the health facility. For example, in clients with trauma or severe chronic illnesses, the teams can provide coordinated approaches of specialty so that all the issues affecting the patient are treated accurately. Second, they act as centres of research and education where people, who need to develop their skills to provide proper care in the future, study Also, hospitals help progress knowledge in the field and make essential innovations. Therefore, besides providing critical patient services, hospitals are instrumental in shaping future health care solutions and instruction.

Keloid Treatment Market Regional Insights:

North America is Expected to Dominate the Market Over the Forecast period

• North America predominantly led by the United States is the leading market for keloid treatment due to the increasing incidence of keloids in this region. Keloids –skin aberrations that overgrow a scar and expand beyond the initial site of injury –impact a large population for which tools to treat the condition are in high demand. This problem has been made much easier for clinicians to manage due to progress in the type of treatment options like corticosteroid Injections, laser treatment and surgery among others. It is also good because other interventions like using silicone gel sheets and pressure therapies are equally effective and patients love using them. Moreover, newer treatment modalities such as immunotherapy and cryotherapy have also been brought into the treatment offering thus allowing the center to meet different needs of diverse clients.
• The developed healthcare infrastructure of the country like USA is one of the most prominent factor behind the growth of the keloid treatment market. Strong emphasis on research aspect and clinical trial means that many experiments to introduce new treatment techniques are being conducted, thus increasing the utilization rates for such technologies in clinical practice. Moreover it is known that more healthcare providers become aware about the formation and how to deal with keloids which lead to better patient care. Due to such awareness creation crusades as well as educational efforts targeted at both the patient and provider levels, the general knowledge base relating to keloids and the factors thought to underlie them, as well as treatment modalities has been well boosted. This growing awareness helps in early diagnosis and hence early treatment thus increasing market demand since patients want to get the best ways of treating their keloid scars.

Active Key Players in the Keloid Treatment Market

• Hoffmann-La Roche Ltd. (Switzerland)
• Mylan N.V. (U.S.)
• Pfizer Inc. (U.S.)
• GSK plc (U.K.)
• Novartis AG (Switzerland)
• AstraZeneca (U.K.)
• Sun Pharmaceutical Industries Ltd. (India)
• Merck & Co., Inc. (U.S.)
• Bristol-Myers Squibb Company (U.S.)
• Lilly (U.S.)
• Revitol (U.S.)
• Renovo Group plc (U.K.)
• AVITA Medical (U.S.)
• Other Key Players

Key Industry Developments in the Keloid Treatment Market:

• In April, 2024 AFT Pharmaceuticals has entered into a development deal with Massey Ventures and the Gillies McIndoe Research Institute to provide a topical therapy for hypertrophic and keloid scarring.
• In January 2023, Sonoma Pharmaceuticals, Inc. launched a line of office dispense products, including Regenacyn® Plus, Reliefacyn® Plus, and Rejuvacyn® Plus, designed for skin care professionals. Regenacyn Plus, in particular, has demonstrated in clinical trials its effectiveness in reducing itching and pain associated with keloid and hypertrophic scars, and improving their appearance, texture, and color.
• In March 2023, Galderma introduced FACE by Galderma™, an innovative aesthetic visualization tool that uses augmented reality (AR) to help aesthetic professionals and patients visualize the outcomes of injectable treatments during planning.

Chapter 1: Introduction
 1.1 Scope and Coverage

Chapter 2:Executive Summary

Chapter 3: Market Landscape
 3.1 Market Dynamics
  3.1.1 Drivers
  3.1.2 Restraints
  3.1.3 Opportunities
  3.1.4 Challenges
 3.2 Market Trend Analysis
 3.3 PESTLE Analysis
 3.4 Porter's Five Forces Analysis
 3.5 Industry Value Chain Analysis
 3.6 Ecosystem
 3.7 Regulatory Landscape
 3.8 Price Trend Analysis
 3.9 Patent Analysis
 3.10 Technology Evolution
 3.11 Investment Pockets
 3.12 Import-Export Analysis

Chapter 4: Keloid Treatment Market by Product Type
 4.1 Keloid Treatment Market Snapshot and Growth Engine
 4.2 Keloid Treatment Market Overview
 4.3 Injectables
  4.3.1 Introduction and Market Overview
  4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.3.3 Key Market Trends, Growth Factors and Opportunities
  4.3.4 Injectables: Geographic Segmentation Analysis
 4.4 laser products (carbon dioxide
  4.4.1 Introduction and Market Overview
  4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.4.3 Key Market Trends, Growth Factors and Opportunities
  4.4.4 laser products (carbon dioxide: Geographic Segmentation Analysis
 4.5 pulse-dyed
  4.5.1 Introduction and Market Overview
  4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.5.3 Key Market Trends, Growth Factors and Opportunities
  4.5.4 pulse-dyed: Geographic Segmentation Analysis
 4.6 others)
  4.6.1 Introduction and Market Overview
  4.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.6.3 Key Market Trends, Growth Factors and Opportunities
  4.6.4 others): Geographic Segmentation Analysis
 4.7 topical products (gels
  4.7.1 Introduction and Market Overview
  4.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.7.3 Key Market Trends, Growth Factors and Opportunities
  4.7.4 topical products (gels: Geographic Segmentation Analysis
 4.8 creams
  4.8.1 Introduction and Market Overview
  4.8.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.8.3 Key Market Trends, Growth Factors and Opportunities
  4.8.4 creams: Geographic Segmentation Analysis
 4.9 silicone sheets
  4.9.1 Introduction and Market Overview
  4.9.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.9.3 Key Market Trends, Growth Factors and Opportunities
  4.9.4 silicone sheets: Geographic Segmentation Analysis
 4.10 others)
  4.10.1 Introduction and Market Overview
  4.10.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.10.3 Key Market Trends, Growth Factors and Opportunities
  4.10.4 others): Geographic Segmentation Analysis

Chapter 5: Keloid Treatment Market by Treatment Type
 5.1 Keloid Treatment Market Snapshot and Growth Engine
 5.2 Keloid Treatment Market Overview
 5.3 Radiation Therapy
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 Radiation Therapy: Geographic Segmentation Analysis

Chapter 6: Keloid Treatment Market by End-Users
 6.1 Keloid Treatment Market Snapshot and Growth Engine
 6.2 Keloid Treatment Market Overview
 6.3 Hospitals
  6.3.1 Introduction and Market Overview
  6.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.3.3 Key Market Trends, Growth Factors and Opportunities
  6.3.4 Hospitals: Geographic Segmentation Analysis
 6.4 Specialty Clinics
  6.4.1 Introduction and Market Overview
  6.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.4.3 Key Market Trends, Growth Factors and Opportunities
  6.4.4 Specialty Clinics: Geographic Segmentation Analysis
 6.5 Homecare
  6.5.1 Introduction and Market Overview
  6.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.5.3 Key Market Trends, Growth Factors and Opportunities
  6.5.4 Homecare: Geographic Segmentation Analysis
 6.6 Others
  6.6.1 Introduction and Market Overview
  6.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.6.3 Key Market Trends, Growth Factors and Opportunities
  6.6.4 Others: Geographic Segmentation Analysis

Chapter 7: Company Profiles and Competitive Analysis
 7.1 Competitive Landscape
  7.1.1 Competitive Benchmarking
  7.1.2 Keloid Treatment Market Share by Manufacturer (2023)
  7.1.3 Industry BCG Matrix
  7.1.4 Heat Map Analysis
  7.1.5 Mergers and Acquisitions
  
 7.2 HOFFMANN-LA ROCHE LTD (SWITZERLAND)
  7.2.1 Company Overview
  7.2.2 Key Executives
  7.2.3 Company Snapshot
  7.2.4 Role of the Company in the Market
  7.2.5 Sustainability and Social Responsibility
  7.2.6 Operating Business Segments
  7.2.7 Product Portfolio
  7.2.8 Business Performance
  7.2.9 Key Strategic Moves and Recent Developments
  7.2.10 SWOT Analysis
 7.3 MYLAN NV (US)
 7.4 PFIZER INC (US)
 7.5 GSK PLC (UK)
 7.6 NOVARTIS AG (SWITZERLAND)
 7.7 ASTRAZENECA (UK)
 7.8 SUN PHARMACEUTICAL INDUSTRIES LTD (INDIA)
 7.9 MERCK & CO INC (US)
 7.10 BRISTOL-MYERS SQUIBB COMPANY (US)
 7.11 LILLY (US)
 7.12 REVITOL (US)
 7.13 RENOVO GROUP PLC (UK)
 7.14 AVITA MEDICAL (US)
 7.15 OTHER KEY PLAYERS

Chapter 8: Global Keloid Treatment Market By Region
 8.1 Overview
 8.2. North America Keloid Treatment Market
  8.2.1 Key Market Trends, Growth Factors and Opportunities
  8.2.2 Top Key Companies
  8.2.3 Historic and Forecasted Market Size by Segments
  8.2.4 Historic and Forecasted Market Size By Product Type
  8.2.4.1 Injectables
  8.2.4.2 laser products (carbon dioxide
  8.2.4.3 pulse-dyed
  8.2.4.4 others)
  8.2.4.5 topical products (gels
  8.2.4.6 creams
  8.2.4.7 silicone sheets
  8.2.4.8 others)
  8.2.5 Historic and Forecasted Market Size By Treatment Type
  8.2.5.1 Radiation Therapy
  8.2.6 Historic and Forecasted Market Size By End-Users
  8.2.6.1 Hospitals
  8.2.6.2 Specialty Clinics
  8.2.6.3 Homecare
  8.2.6.4 Others
  8.2.7 Historic and Forecast Market Size by Country
  8.2.7.1 US
  8.2.7.2 Canada
  8.2.7.3 Mexico
 8.3. Eastern Europe Keloid Treatment Market
  8.3.1 Key Market Trends, Growth Factors and Opportunities
  8.3.2 Top Key Companies
  8.3.3 Historic and Forecasted Market Size by Segments
  8.3.4 Historic and Forecasted Market Size By Product Type
  8.3.4.1 Injectables
  8.3.4.2 laser products (carbon dioxide
  8.3.4.3 pulse-dyed
  8.3.4.4 others)
  8.3.4.5 topical products (gels
  8.3.4.6 creams
  8.3.4.7 silicone sheets
  8.3.4.8 others)
  8.3.5 Historic and Forecasted Market Size By Treatment Type
  8.3.5.1 Radiation Therapy
  8.3.6 Historic and Forecasted Market Size By End-Users
  8.3.6.1 Hospitals
  8.3.6.2 Specialty Clinics
  8.3.6.3 Homecare
  8.3.6.4 Others
  8.3.7 Historic and Forecast Market Size by Country
  8.3.7.1 Bulgaria
  8.3.7.2 The Czech Republic
  8.3.7.3 Hungary
  8.3.7.4 Poland
  8.3.7.5 Romania
  8.3.7.6 Rest of Eastern Europe
 8.4. Western Europe Keloid Treatment Market
  8.4.1 Key Market Trends, Growth Factors and Opportunities
  8.4.2 Top Key Companies
  8.4.3 Historic and Forecasted Market Size by Segments
  8.4.4 Historic and Forecasted Market Size By Product Type
  8.4.4.1 Injectables
  8.4.4.2 laser products (carbon dioxide
  8.4.4.3 pulse-dyed
  8.4.4.4 others)
  8.4.4.5 topical products (gels
  8.4.4.6 creams
  8.4.4.7 silicone sheets
  8.4.4.8 others)
  8.4.5 Historic and Forecasted Market Size By Treatment Type
  8.4.5.1 Radiation Therapy
  8.4.6 Historic and Forecasted Market Size By End-Users
  8.4.6.1 Hospitals
  8.4.6.2 Specialty Clinics
  8.4.6.3 Homecare
  8.4.6.4 Others
  8.4.7 Historic and Forecast Market Size by Country
  8.4.7.1 Germany
  8.4.7.2 UK
  8.4.7.3 France
  8.4.7.4 Netherlands
  8.4.7.5 Italy
  8.4.7.6 Russia
  8.4.7.7 Spain
  8.4.7.8 Rest of Western Europe
 8.5. Asia Pacific Keloid Treatment Market
  8.5.1 Key Market Trends, Growth Factors and Opportunities
  8.5.2 Top Key Companies
  8.5.3 Historic and Forecasted Market Size by Segments
  8.5.4 Historic and Forecasted Market Size By Product Type
  8.5.4.1 Injectables
  8.5.4.2 laser products (carbon dioxide
  8.5.4.3 pulse-dyed
  8.5.4.4 others)
  8.5.4.5 topical products (gels
  8.5.4.6 creams
  8.5.4.7 silicone sheets
  8.5.4.8 others)
  8.5.5 Historic and Forecasted Market Size By Treatment Type
  8.5.5.1 Radiation Therapy
  8.5.6 Historic and Forecasted Market Size By End-Users
  8.5.6.1 Hospitals
  8.5.6.2 Specialty Clinics
  8.5.6.3 Homecare
  8.5.6.4 Others
  8.5.7 Historic and Forecast Market Size by Country
  8.5.7.1 China
  8.5.7.2 India
  8.5.7.3 Japan
  8.5.7.4 South Korea
  8.5.7.5 Malaysia
  8.5.7.6 Thailand
  8.5.7.7 Vietnam
  8.5.7.8 The Philippines
  8.5.7.9 Australia
  8.5.7.10 New Zealand
  8.5.7.11 Rest of APAC
 8.6. Middle East & Africa Keloid Treatment Market
  8.6.1 Key Market Trends, Growth Factors and Opportunities
  8.6.2 Top Key Companies
  8.6.3 Historic and Forecasted Market Size by Segments
  8.6.4 Historic and Forecasted Market Size By Product Type
  8.6.4.1 Injectables
  8.6.4.2 laser products (carbon dioxide
  8.6.4.3 pulse-dyed
  8.6.4.4 others)
  8.6.4.5 topical products (gels
  8.6.4.6 creams
  8.6.4.7 silicone sheets
  8.6.4.8 others)
  8.6.5 Historic and Forecasted Market Size By Treatment Type
  8.6.5.1 Radiation Therapy
  8.6.6 Historic and Forecasted Market Size By End-Users
  8.6.6.1 Hospitals
  8.6.6.2 Specialty Clinics
  8.6.6.3 Homecare
  8.6.6.4 Others
  8.6.7 Historic and Forecast Market Size by Country
  8.6.7.1 Turkey
  8.6.7.2 Bahrain
  8.6.7.3 Kuwait
  8.6.7.4 Saudi Arabia
  8.6.7.5 Qatar
  8.6.7.6 UAE
  8.6.7.7 Israel
  8.6.7.8 South Africa
 8.7. South America Keloid Treatment Market
  8.7.1 Key Market Trends, Growth Factors and Opportunities
  8.7.2 Top Key Companies
  8.7.3 Historic and Forecasted Market Size by Segments
  8.7.4 Historic and Forecasted Market Size By Product Type
  8.7.4.1 Injectables
  8.7.4.2 laser products (carbon dioxide
  8.7.4.3 pulse-dyed
  8.7.4.4 others)
  8.7.4.5 topical products (gels
  8.7.4.6 creams
  8.7.4.7 silicone sheets
  8.7.4.8 others)
  8.7.5 Historic and Forecasted Market Size By Treatment Type
  8.7.5.1 Radiation Therapy
  8.7.6 Historic and Forecasted Market Size By End-Users
  8.7.6.1 Hospitals
  8.7.6.2 Specialty Clinics
  8.7.6.3 Homecare
  8.7.6.4 Others
  8.7.7 Historic and Forecast Market Size by Country
  8.7.7.1 Brazil
  8.7.7.2 Argentina
  8.7.7.3 Rest of SA

Chapter 9 Analyst Viewpoint and Conclusion
9.1 Recommendations and Concluding Analysis
9.2 Potential Market Strategies

Chapter 10 Research Methodology
10.1 Research Process
10.2 Primary Research
10.3 Secondary Research